RxDoctor Payments Data

Brooke Jones, PA

Physician Assistant · Goldsboro, NCNPI 1912977059

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $172,573 of the $259,023 with a category attached, or 66.6%. 39 manufacturers reported payments, led by UCB, Inc. at 34.6% of the total. 2025 is the largest year on record at $97,257, 4.0 times the $24,607 reported in 2021. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$259,023in general payments, 2019–2025

Across 1,514 payments — averaging $171.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$90K
  • AbbVie$53K
  • Johnson & Johnson$50K
  • Sun Pharmaceutical Industries Inc.$25K
  • Lilly USA, LLC$22K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$3K
  • plus $16K from 33 others

What the payments were for

  • Consulting fees$18,0687%
  • Speaking & faculty fees$172,57367%
  • Travel & lodging$39,14115%
  • Food & beverage$28,45311%
  • Education$7890%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$259,023 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$163,104
Medicare patients
535
Services billed
3,318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab33$227,950
Bimzelx AutoinjectorBimekizumab-Bkzx15$217,212
Humira(Cf) PenAdalimumab11$153,068
Cosentyx Unoready PenSecukinumab13$98,262
XolairOmalizumab16$44,016
Metronidazole116$6,584
Azelaic Acid42$5,585
Clobetasol Propionate102$5,279
Doxycycline Hyclate118$2,448
Fluocinonide34$1,459
Hydrocortisone Butyrate11$1,353
ValacyclovirValacyclovir Hcl28$1,343
Fluocinolone Acetonide27$1,144
Spironolactone51$1,011
Triamcinolone Acetonide42$778

Paid to pharmacies, not to this prescriber.

Other physician assistant in Goldsboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →